Fundraising FoxVibrant Therapeutics
2 known investors
Find your way into Vibrant Therapeutics
Sign up to see every warm intro you have to Vibrant Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vibrant Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vibrant Therapeutics develops multispecific antibody-based prodrugs with conditional activation and targeted delivery for patients with oncological, autoimmune, and neurological diseases. It runs computational drug discovery platforms (BumbleBee, LogicBee, NeuroBee) that combine proteomics analysis and antibody engineering to design biotherapeutics.
Investors · 2
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
Pfizer Venturesreported
How we know: convention.bio.org · Not right? Tell us
In the news
Frequently asked questions
- What does Vibrant Therapeutics do?
- Vibrant Therapeutics develops multispecific antibody-based prodrugs with conditional activation and targeted delivery for patients with oncological, autoimmune, and neurological diseases. It runs computational drug discovery platforms (BumbleBee, LogicBee, NeuroBee) that combine proteomics analysis and antibody engineering to design biotherapeutics.
- Who are Vibrant Therapeutics's investors?
- Vibrant Therapeutics's investors include Pfizer Venture Investments, Pfizer Ventures.